Back grey_arrow_rt.gif
Roche, GSK say FDA backs once-monthly bone drug
  WASHINGTON (Reuters) - The U.S. Food and Drug Administration has approved a monthly version of osteoporosis drug Boniva, Roche Holding AG and GlaxoSmithKline Plc said on Friday.
A daily version of the pill was first approved by the FDA in 2003, but the companies never launched the product as they explored a more convenient dosing for the medicine to treat brittle bones in post-menopausal women.
SOURCE: Annals of Neurology March, 2005.


Copyright © 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
  icon paper stack View Older Articles   Back to Top